ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-Neuropilin-1 Antibody Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-17V13030
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti Neuropilin 1 Antibody Market Research Report 2023
BUY CHAPTERS

Global Anti-Neuropilin-1 Antibody Market Research Report 2024

Code: QYRE-Auto-17V13030
Report
April 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lifespan Biosciences Inc.
Thermo Fisher
RayBiotech
MyBioSource
Cusabio
Boster Biological Technology
Biomatik
Assay Genie
Abbexa
CLOUD-CLONE CORP.
Innovative Research
ZodelBiotec Ltd.

Anti-Neuropilin-1 Antibody Market

Anti-Neuropilin-1 Antibody is an unconjugated antibody to Anti-Neuropilin-1.
The global Anti-Neuropilin-1 Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anti-Neuropilin-1 Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anti-Neuropilin-1 Antibody is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Anti-Neuropilin-1 Antibody include LifeSpan BioSciences, Inc, Thermo Fisher, RayBiotech, Inc., MyBiosource, Inc., Shanghai Korain Biotech Co., Ltd., Wuhan Fine Biotech Co., Ltd., CUSABIO, Boster Biological Technology and Biomatik, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anti-Neuropilin-1 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Neuropilin-1 Antibody.

Report Scope

The Anti-Neuropilin-1 Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Neuropilin-1 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Neuropilin-1 Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Anti-Neuropilin-1 Antibody Market Report

Report Metric Details
Report Name Anti-Neuropilin-1 Antibody Market
Segment by Type
  • Monoclonal Antibody
  • Polyclonal Antibody
Segment by Application
  • Flow Cytometry
  • ELISA
  • Western Blot
  • Immunoprecipitation
  • Immunofluorescence
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company LifeSpan BioSciences, Inc, Thermo Fisher, RayBiotech, Inc., MyBiosource, Inc., Shanghai Korain Biotech Co., Ltd., Wuhan Fine Biotech Co., Ltd., CUSABIO, Boster Biological Technology, Biomatik, Assay Genie, Abbexa, CLOUD-CLONE CORP., Innovative Research, ZodelBiotec Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anti-Neuropilin-1 Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anti-Neuropilin-1 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-Neuropilin-1 Antibody Market report?

Ans: The main players in the Anti-Neuropilin-1 Antibody Market are LifeSpan BioSciences, Inc, Thermo Fisher, RayBiotech, Inc., MyBiosource, Inc., Shanghai Korain Biotech Co., Ltd., Wuhan Fine Biotech Co., Ltd., CUSABIO, Boster Biological Technology, Biomatik, Assay Genie, Abbexa, CLOUD-CLONE CORP., Innovative Research, ZodelBiotec Ltd.

What are the Application segmentation covered in the Anti-Neuropilin-1 Antibody Market report?

Ans: The Applications covered in the Anti-Neuropilin-1 Antibody Market report are Flow Cytometry, ELISA, Western Blot, Immunoprecipitation, Immunofluorescence, Others

What are the Type segmentation covered in the Anti-Neuropilin-1 Antibody Market report?

Ans: The Types covered in the Anti-Neuropilin-1 Antibody Market report are Monoclonal Antibody, Polyclonal Antibody

1 Anti-Neuropilin-1 Antibody Market Overview
1.1 Product Overview and Scope of Anti-Neuropilin-1 Antibody
1.2 Anti-Neuropilin-1 Antibody Segment by Type
1.2.1 Global Anti-Neuropilin-1 Antibody Market Value Comparison by Type (2024-2030)
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Anti-Neuropilin-1 Antibody Segment by Application
1.3.1 Global Anti-Neuropilin-1 Antibody Market Value by Application: (2024-2030)
1.3.2 Flow Cytometry
1.3.3 ELISA
1.3.4 Western Blot
1.3.5 Immunoprecipitation
1.3.6 Immunofluorescence
1.3.7 Others
1.4 Global Anti-Neuropilin-1 Antibody Market Size Estimates and Forecasts
1.4.1 Global Anti-Neuropilin-1 Antibody Revenue 2019-2030
1.4.2 Global Anti-Neuropilin-1 Antibody Sales 2019-2030
1.4.3 Global Anti-Neuropilin-1 Antibody Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-Neuropilin-1 Antibody Market Competition by Manufacturers
2.1 Global Anti-Neuropilin-1 Antibody Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-Neuropilin-1 Antibody Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-Neuropilin-1 Antibody Average Price by Manufacturers (2019-2024)
2.4 Global Anti-Neuropilin-1 Antibody Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Neuropilin-1 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Neuropilin-1 Antibody, Product Type & Application
2.7 Anti-Neuropilin-1 Antibody Market Competitive Situation and Trends
2.7.1 Anti-Neuropilin-1 Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Neuropilin-1 Antibody Players Market Share by Revenue
2.7.3 Global Anti-Neuropilin-1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Neuropilin-1 Antibody Retrospective Market Scenario by Region
3.1 Global Anti-Neuropilin-1 Antibody Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-Neuropilin-1 Antibody Global Anti-Neuropilin-1 Antibody Sales by Region: 2019-2030
3.2.1 Global Anti-Neuropilin-1 Antibody Sales by Region: 2019-2024
3.2.2 Global Anti-Neuropilin-1 Antibody Sales by Region: 2025-2030
3.3 Global Anti-Neuropilin-1 Antibody Global Anti-Neuropilin-1 Antibody Revenue by Region: 2019-2030
3.3.1 Global Anti-Neuropilin-1 Antibody Revenue by Region: 2019-2024
3.3.2 Global Anti-Neuropilin-1 Antibody Revenue by Region: 2025-2030
3.4 North America Anti-Neuropilin-1 Antibody Market Facts & Figures by Country
3.4.1 North America Anti-Neuropilin-1 Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-Neuropilin-1 Antibody Sales by Country (2019-2030)
3.4.3 North America Anti-Neuropilin-1 Antibody Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-Neuropilin-1 Antibody Market Facts & Figures by Country
3.5.1 Europe Anti-Neuropilin-1 Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-Neuropilin-1 Antibody Sales by Country (2019-2030)
3.5.3 Europe Anti-Neuropilin-1 Antibody Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Neuropilin-1 Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Neuropilin-1 Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-Neuropilin-1 Antibody Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-Neuropilin-1 Antibody Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-Neuropilin-1 Antibody Market Facts & Figures by Country
3.7.1 Latin America Anti-Neuropilin-1 Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-Neuropilin-1 Antibody Sales by Country (2019-2030)
3.7.3 Latin America Anti-Neuropilin-1 Antibody Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Neuropilin-1 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Neuropilin-1 Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-Neuropilin-1 Antibody Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-Neuropilin-1 Antibody Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Neuropilin-1 Antibody Sales by Type (2019-2030)
4.1.1 Global Anti-Neuropilin-1 Antibody Sales by Type (2019-2024)
4.1.2 Global Anti-Neuropilin-1 Antibody Sales by Type (2025-2030)
4.1.3 Global Anti-Neuropilin-1 Antibody Sales Market Share by Type (2019-2030)
4.2 Global Anti-Neuropilin-1 Antibody Revenue by Type (2019-2030)
4.2.1 Global Anti-Neuropilin-1 Antibody Revenue by Type (2019-2024)
4.2.2 Global Anti-Neuropilin-1 Antibody Revenue by Type (2025-2030)
4.2.3 Global Anti-Neuropilin-1 Antibody Revenue Market Share by Type (2019-2030)
4.3 Global Anti-Neuropilin-1 Antibody Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-Neuropilin-1 Antibody Sales by Application (2019-2030)
5.1.1 Global Anti-Neuropilin-1 Antibody Sales by Application (2019-2024)
5.1.2 Global Anti-Neuropilin-1 Antibody Sales by Application (2025-2030)
5.1.3 Global Anti-Neuropilin-1 Antibody Sales Market Share by Application (2019-2030)
5.2 Global Anti-Neuropilin-1 Antibody Revenue by Application (2019-2030)
5.2.1 Global Anti-Neuropilin-1 Antibody Revenue by Application (2019-2024)
5.2.2 Global Anti-Neuropilin-1 Antibody Revenue by Application (2025-2030)
5.2.3 Global Anti-Neuropilin-1 Antibody Revenue Market Share by Application (2019-2030)
5.3 Global Anti-Neuropilin-1 Antibody Price by Application (2019-2030)
6 Key Companies Profiled
6.1 LifeSpan BioSciences, Inc
6.1.1 LifeSpan BioSciences, Inc Corporation Information
6.1.2 LifeSpan BioSciences, Inc Description and Business Overview
6.1.3 LifeSpan BioSciences, Inc Anti-Neuropilin-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.1.4 LifeSpan BioSciences, Inc Anti-Neuropilin-1 Antibody Product Portfolio
6.1.5 LifeSpan BioSciences, Inc Recent Developments/Updates
6.2 Thermo Fisher
6.2.1 Thermo Fisher Corporation Information
6.2.2 Thermo Fisher Description and Business Overview
6.2.3 Thermo Fisher Anti-Neuropilin-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Thermo Fisher Anti-Neuropilin-1 Antibody Product Portfolio
6.2.5 Thermo Fisher Recent Developments/Updates
6.3 RayBiotech, Inc.
6.3.1 RayBiotech, Inc. Corporation Information
6.3.2 RayBiotech, Inc. Description and Business Overview
6.3.3 RayBiotech, Inc. Anti-Neuropilin-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.3.4 RayBiotech, Inc. Anti-Neuropilin-1 Antibody Product Portfolio
6.3.5 RayBiotech, Inc. Recent Developments/Updates
6.4 MyBiosource, Inc.
6.4.1 MyBiosource, Inc. Corporation Information
6.4.2 MyBiosource, Inc. Description and Business Overview
6.4.3 MyBiosource, Inc. Anti-Neuropilin-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MyBiosource, Inc. Anti-Neuropilin-1 Antibody Product Portfolio
6.4.5 MyBiosource, Inc. Recent Developments/Updates
6.5 Shanghai Korain Biotech Co., Ltd.
6.5.1 Shanghai Korain Biotech Co., Ltd. Corporation Information
6.5.2 Shanghai Korain Biotech Co., Ltd. Description and Business Overview
6.5.3 Shanghai Korain Biotech Co., Ltd. Anti-Neuropilin-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shanghai Korain Biotech Co., Ltd. Anti-Neuropilin-1 Antibody Product Portfolio
6.5.5 Shanghai Korain Biotech Co., Ltd. Recent Developments/Updates
6.6 Wuhan Fine Biotech Co., Ltd.
6.6.1 Wuhan Fine Biotech Co., Ltd. Corporation Information
6.6.2 Wuhan Fine Biotech Co., Ltd. Description and Business Overview
6.6.3 Wuhan Fine Biotech Co., Ltd. Anti-Neuropilin-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Wuhan Fine Biotech Co., Ltd. Anti-Neuropilin-1 Antibody Product Portfolio
6.6.5 Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
6.7 CUSABIO
6.6.1 CUSABIO Corporation Information
6.6.2 CUSABIO Description and Business Overview
6.6.3 CUSABIO Anti-Neuropilin-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CUSABIO Anti-Neuropilin-1 Antibody Product Portfolio
6.7.5 CUSABIO Recent Developments/Updates
6.8 Boster Biological Technology
6.8.1 Boster Biological Technology Corporation Information
6.8.2 Boster Biological Technology Description and Business Overview
6.8.3 Boster Biological Technology Anti-Neuropilin-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Boster Biological Technology Anti-Neuropilin-1 Antibody Product Portfolio
6.8.5 Boster Biological Technology Recent Developments/Updates
6.9 Biomatik
6.9.1 Biomatik Corporation Information
6.9.2 Biomatik Description and Business Overview
6.9.3 Biomatik Anti-Neuropilin-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biomatik Anti-Neuropilin-1 Antibody Product Portfolio
6.9.5 Biomatik Recent Developments/Updates
6.10 Assay Genie
6.10.1 Assay Genie Corporation Information
6.10.2 Assay Genie Description and Business Overview
6.10.3 Assay Genie Anti-Neuropilin-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Assay Genie Anti-Neuropilin-1 Antibody Product Portfolio
6.10.5 Assay Genie Recent Developments/Updates
6.11 Abbexa
6.11.1 Abbexa Corporation Information
6.11.2 Abbexa Anti-Neuropilin-1 Antibody Description and Business Overview
6.11.3 Abbexa Anti-Neuropilin-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Abbexa Anti-Neuropilin-1 Antibody Product Portfolio
6.11.5 Abbexa Recent Developments/Updates
6.12 CLOUD-CLONE CORP.
6.12.1 CLOUD-CLONE CORP. Corporation Information
6.12.2 CLOUD-CLONE CORP. Anti-Neuropilin-1 Antibody Description and Business Overview
6.12.3 CLOUD-CLONE CORP. Anti-Neuropilin-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CLOUD-CLONE CORP. Anti-Neuropilin-1 Antibody Product Portfolio
6.12.5 CLOUD-CLONE CORP. Recent Developments/Updates
6.13 Innovative Research
6.13.1 Innovative Research Corporation Information
6.13.2 Innovative Research Anti-Neuropilin-1 Antibody Description and Business Overview
6.13.3 Innovative Research Anti-Neuropilin-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Innovative Research Anti-Neuropilin-1 Antibody Product Portfolio
6.13.5 Innovative Research Recent Developments/Updates
6.14 ZodelBiotec Ltd.
6.14.1 ZodelBiotec Ltd. Corporation Information
6.14.2 ZodelBiotec Ltd. Anti-Neuropilin-1 Antibody Description and Business Overview
6.14.3 ZodelBiotec Ltd. Anti-Neuropilin-1 Antibody Sales, Revenue and Gross Margin (2019-2024)
6.14.4 ZodelBiotec Ltd. Anti-Neuropilin-1 Antibody Product Portfolio
6.14.5 ZodelBiotec Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Neuropilin-1 Antibody Industry Chain Analysis
7.2 Anti-Neuropilin-1 Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Neuropilin-1 Antibody Production Mode & Process
7.4 Anti-Neuropilin-1 Antibody Sales and Marketing
7.4.1 Anti-Neuropilin-1 Antibody Sales Channels
7.4.2 Anti-Neuropilin-1 Antibody Distributors
7.5 Anti-Neuropilin-1 Antibody Customers
8 Anti-Neuropilin-1 Antibody Market Dynamics
8.1 Anti-Neuropilin-1 Antibody Industry Trends
8.2 Anti-Neuropilin-1 Antibody Market Drivers
8.3 Anti-Neuropilin-1 Antibody Market Challenges
8.4 Anti-Neuropilin-1 Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Lifespan Biosciences Inc.
Thermo Fisher
RayBiotech
MyBioSource
Cusabio
Boster Biological Technology
Biomatik
Assay Genie
Abbexa
CLOUD-CLONE CORP.
Innovative Research
ZodelBiotec Ltd.
List of Tables
    Table 1. Global Anti-Neuropilin-1 Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Anti-Neuropilin-1 Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Anti-Neuropilin-1 Antibody Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Anti-Neuropilin-1 Antibody Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Anti-Neuropilin-1 Antibody Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Anti-Neuropilin-1 Antibody Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Anti-Neuropilin-1 Antibody Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Anti-Neuropilin-1 Antibody Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Anti-Neuropilin-1 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Anti-Neuropilin-1 Antibody, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Anti-Neuropilin-1 Antibody, Product Type & Application
    Table 12. Global Key Manufacturers of Anti-Neuropilin-1 Antibody, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Anti-Neuropilin-1 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Neuropilin-1 Antibody as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Anti-Neuropilin-1 Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Anti-Neuropilin-1 Antibody Sales by Region (2019-2024) & (K Units)
    Table 18. Global Anti-Neuropilin-1 Antibody Sales Market Share by Region (2019-2024)
    Table 19. Global Anti-Neuropilin-1 Antibody Sales by Region (2025-2030) & (K Units)
    Table 20. Global Anti-Neuropilin-1 Antibody Sales Market Share by Region (2025-2030)
    Table 21. Global Anti-Neuropilin-1 Antibody Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Anti-Neuropilin-1 Antibody Revenue Market Share by Region (2019-2024)
    Table 23. Global Anti-Neuropilin-1 Antibody Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Anti-Neuropilin-1 Antibody Revenue Market Share by Region (2025-2030)
    Table 25. North America Anti-Neuropilin-1 Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Anti-Neuropilin-1 Antibody Sales by Country (2019-2024) & (K Units)
    Table 27. North America Anti-Neuropilin-1 Antibody Sales by Country (2025-2030) & (K Units)
    Table 28. North America Anti-Neuropilin-1 Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Anti-Neuropilin-1 Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Anti-Neuropilin-1 Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Anti-Neuropilin-1 Antibody Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Anti-Neuropilin-1 Antibody Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Anti-Neuropilin-1 Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Anti-Neuropilin-1 Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Anti-Neuropilin-1 Antibody Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Anti-Neuropilin-1 Antibody Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Anti-Neuropilin-1 Antibody Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Anti-Neuropilin-1 Antibody Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Anti-Neuropilin-1 Antibody Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Anti-Neuropilin-1 Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Anti-Neuropilin-1 Antibody Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Anti-Neuropilin-1 Antibody Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Anti-Neuropilin-1 Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Anti-Neuropilin-1 Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Anti-Neuropilin-1 Antibody Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Anti-Neuropilin-1 Antibody Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Anti-Neuropilin-1 Antibody Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Anti-Neuropilin-1 Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Anti-Neuropilin-1 Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Anti-Neuropilin-1 Antibody Sales (K Units) by Type (2019-2024)
    Table 51. Global Anti-Neuropilin-1 Antibody Sales (K Units) by Type (2025-2030)
    Table 52. Global Anti-Neuropilin-1 Antibody Sales Market Share by Type (2019-2024)
    Table 53. Global Anti-Neuropilin-1 Antibody Sales Market Share by Type (2025-2030)
    Table 54. Global Anti-Neuropilin-1 Antibody Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Anti-Neuropilin-1 Antibody Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Anti-Neuropilin-1 Antibody Revenue Market Share by Type (2019-2024)
    Table 57. Global Anti-Neuropilin-1 Antibody Revenue Market Share by Type (2025-2030)
    Table 58. Global Anti-Neuropilin-1 Antibody Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Anti-Neuropilin-1 Antibody Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Anti-Neuropilin-1 Antibody Sales (K Units) by Application (2019-2024)
    Table 61. Global Anti-Neuropilin-1 Antibody Sales (K Units) by Application (2025-2030)
    Table 62. Global Anti-Neuropilin-1 Antibody Sales Market Share by Application (2019-2024)
    Table 63. Global Anti-Neuropilin-1 Antibody Sales Market Share by Application (2025-2030)
    Table 64. Global Anti-Neuropilin-1 Antibody Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Anti-Neuropilin-1 Antibody Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Anti-Neuropilin-1 Antibody Revenue Market Share by Application (2019-2024)
    Table 67. Global Anti-Neuropilin-1 Antibody Revenue Market Share by Application (2025-2030)
    Table 68. Global Anti-Neuropilin-1 Antibody Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Anti-Neuropilin-1 Antibody Price (US$/Unit) by Application (2025-2030)
    Table 70. LifeSpan BioSciences, Inc Corporation Information
    Table 71. LifeSpan BioSciences, Inc Description and Business Overview
    Table 72. LifeSpan BioSciences, Inc Anti-Neuropilin-1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. LifeSpan BioSciences, Inc Anti-Neuropilin-1 Antibody Product
    Table 74. LifeSpan BioSciences, Inc Recent Developments/Updates
    Table 75. Thermo Fisher Corporation Information
    Table 76. Thermo Fisher Description and Business Overview
    Table 77. Thermo Fisher Anti-Neuropilin-1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Thermo Fisher Anti-Neuropilin-1 Antibody Product
    Table 79. Thermo Fisher Recent Developments/Updates
    Table 80. RayBiotech, Inc. Corporation Information
    Table 81. RayBiotech, Inc. Description and Business Overview
    Table 82. RayBiotech, Inc. Anti-Neuropilin-1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. RayBiotech, Inc. Anti-Neuropilin-1 Antibody Product
    Table 84. RayBiotech, Inc. Recent Developments/Updates
    Table 85. MyBiosource, Inc. Corporation Information
    Table 86. MyBiosource, Inc. Description and Business Overview
    Table 87. MyBiosource, Inc. Anti-Neuropilin-1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. MyBiosource, Inc. Anti-Neuropilin-1 Antibody Product
    Table 89. MyBiosource, Inc. Recent Developments/Updates
    Table 90. Shanghai Korain Biotech Co., Ltd. Corporation Information
    Table 91. Shanghai Korain Biotech Co., Ltd. Description and Business Overview
    Table 92. Shanghai Korain Biotech Co., Ltd. Anti-Neuropilin-1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Shanghai Korain Biotech Co., Ltd. Anti-Neuropilin-1 Antibody Product
    Table 94. Shanghai Korain Biotech Co., Ltd. Recent Developments/Updates
    Table 95. Wuhan Fine Biotech Co., Ltd. Corporation Information
    Table 96. Wuhan Fine Biotech Co., Ltd. Description and Business Overview
    Table 97. Wuhan Fine Biotech Co., Ltd. Anti-Neuropilin-1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Wuhan Fine Biotech Co., Ltd. Anti-Neuropilin-1 Antibody Product
    Table 99. Wuhan Fine Biotech Co., Ltd. Recent Developments/Updates
    Table 100. CUSABIO Corporation Information
    Table 101. CUSABIO Description and Business Overview
    Table 102. CUSABIO Anti-Neuropilin-1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. CUSABIO Anti-Neuropilin-1 Antibody Product
    Table 104. CUSABIO Recent Developments/Updates
    Table 105. Boster Biological Technology Corporation Information
    Table 106. Boster Biological Technology Description and Business Overview
    Table 107. Boster Biological Technology Anti-Neuropilin-1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Boster Biological Technology Anti-Neuropilin-1 Antibody Product
    Table 109. Boster Biological Technology Recent Developments/Updates
    Table 110. Biomatik Corporation Information
    Table 111. Biomatik Description and Business Overview
    Table 112. Biomatik Anti-Neuropilin-1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Biomatik Anti-Neuropilin-1 Antibody Product
    Table 114. Biomatik Recent Developments/Updates
    Table 115. Assay Genie Corporation Information
    Table 116. Assay Genie Description and Business Overview
    Table 117. Assay Genie Anti-Neuropilin-1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Assay Genie Anti-Neuropilin-1 Antibody Product
    Table 119. Assay Genie Recent Developments/Updates
    Table 120. Abbexa Corporation Information
    Table 121. Abbexa Description and Business Overview
    Table 122. Abbexa Anti-Neuropilin-1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Abbexa Anti-Neuropilin-1 Antibody Product
    Table 124. Abbexa Recent Developments/Updates
    Table 125. CLOUD-CLONE CORP. Corporation Information
    Table 126. CLOUD-CLONE CORP. Description and Business Overview
    Table 127. CLOUD-CLONE CORP. Anti-Neuropilin-1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. CLOUD-CLONE CORP. Anti-Neuropilin-1 Antibody Product
    Table 129. CLOUD-CLONE CORP. Recent Developments/Updates
    Table 130. Innovative Research Corporation Information
    Table 131. Innovative Research Description and Business Overview
    Table 132. Innovative Research Anti-Neuropilin-1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Innovative Research Anti-Neuropilin-1 Antibody Product
    Table 134. Innovative Research Recent Developments/Updates
    Table 135. ZodelBiotec Ltd. Corporation Information
    Table 136. ZodelBiotec Ltd. Description and Business Overview
    Table 137. ZodelBiotec Ltd. Anti-Neuropilin-1 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. ZodelBiotec Ltd. Anti-Neuropilin-1 Antibody Product
    Table 139. ZodelBiotec Ltd. Recent Developments/Updates
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Anti-Neuropilin-1 Antibody Distributors List
    Table 143. Anti-Neuropilin-1 Antibody Customers List
    Table 144. Anti-Neuropilin-1 Antibody Market Trends
    Table 145. Anti-Neuropilin-1 Antibody Market Drivers
    Table 146. Anti-Neuropilin-1 Antibody Market Challenges
    Table 147. Anti-Neuropilin-1 Antibody Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Anti-Neuropilin-1 Antibody
    Figure 2. Global Anti-Neuropilin-1 Antibody Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Anti-Neuropilin-1 Antibody Market Share by Type in 2023 & 2030
    Figure 4. Monoclonal Antibody Product Picture
    Figure 5. Polyclonal Antibody Product Picture
    Figure 6. Global Anti-Neuropilin-1 Antibody Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Anti-Neuropilin-1 Antibody Market Share by Application in 2023 & 2030
    Figure 8. Flow Cytometry
    Figure 9. ELISA
    Figure 10. Western Blot
    Figure 11. Immunoprecipitation
    Figure 12. Immunofluorescence
    Figure 13. Others
    Figure 14. Global Anti-Neuropilin-1 Antibody Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Anti-Neuropilin-1 Antibody Market Size (2019-2030) & (US$ Million)
    Figure 16. Global Anti-Neuropilin-1 Antibody Sales (2019-2030) & (K Units)
    Figure 17. Global Anti-Neuropilin-1 Antibody Average Price (US$/Unit) & (2019-2030)
    Figure 18. Anti-Neuropilin-1 Antibody Report Years Considered
    Figure 19. Anti-Neuropilin-1 Antibody Sales Share by Manufacturers in 2023
    Figure 20. Global Anti-Neuropilin-1 Antibody Revenue Share by Manufacturers in 2023
    Figure 21. The Global 5 and 10 Largest Anti-Neuropilin-1 Antibody Players: Market Share by Revenue in 2023
    Figure 22. Anti-Neuropilin-1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 23. Global Anti-Neuropilin-1 Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 24. North America Anti-Neuropilin-1 Antibody Sales Market Share by Country (2019-2030)
    Figure 25. North America Anti-Neuropilin-1 Antibody Revenue Market Share by Country (2019-2030)
    Figure 26. United States Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Canada Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Europe Anti-Neuropilin-1 Antibody Sales Market Share by Country (2019-2030)
    Figure 29. Europe Anti-Neuropilin-1 Antibody Revenue Market Share by Country (2019-2030)
    Figure 30. Germany Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. France Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. U.K. Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Italy Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Russia Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Anti-Neuropilin-1 Antibody Sales Market Share by Region (2019-2030)
    Figure 36. Asia Pacific Anti-Neuropilin-1 Antibody Revenue Market Share by Region (2019-2030)
    Figure 37. China Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Japan Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. South Korea Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. India Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Australia Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Anti-Neuropilin-1 Antibody Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Anti-Neuropilin-1 Antibody Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Anti-Neuropilin-1 Antibody Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Anti-Neuropilin-1 Antibody Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE Anti-Neuropilin-1 Antibody Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Anti-Neuropilin-1 Antibody by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Anti-Neuropilin-1 Antibody by Type (2019-2030)
    Figure 56. Global Anti-Neuropilin-1 Antibody Price (US$/Unit) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Anti-Neuropilin-1 Antibody by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Anti-Neuropilin-1 Antibody by Application (2019-2030)
    Figure 59. Global Anti-Neuropilin-1 Antibody Price (US$/Unit) by Application (2019-2030)
    Figure 60. Anti-Neuropilin-1 Antibody Value Chain
    Figure 61. Anti-Neuropilin-1 Antibody Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Nucleolin Antibody Market Research Report 2024
Global Arginase 1 Antibody Market Research Report 2024
Global Galanin Antibody Market Research Report 2024
Global Anti Nestin Antibody Market Research Report 2024
Global Ubiquitin Antibody Market Research Report 2024
Global Peripherin Antibody Market Research Report 2024
Global Synaptophysin Antibody Market Research Report 2024
Global Vinculin Antibody Market Research Report 2024
Global Desmin Antibody Market Research Report 2024
Global Cyclin D1 Antibody Market Research Report 2024
Global Emerin Antibody Market Research Report 2024
Global Nucleolin Monoclonal Antibody Market Research Report 2024
Global Rat Antibody Market Research Report 2024
Global Mouse Antibody Market Research Report 2024
Global Brain Natriuretic Peptide Antibody Market Research Report 2024
Global Renin Antibody Market Research Report 2024
Global Fibronectin Antibody Market Research Report 2024
Global Moesin Antibody Market Research Report 2024
Global Myoglobin Antibody Market Research Report 2024
Global Ubiquitin Monoclonal Antibody Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions